Delivery Order SPE2DB20D3101-SPE2DB25FRTW8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,783.60 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and represents a critical...
- The Defense Logistics Agency awarded a $14,012.49 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 18, 2025. This contract represents a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) in...
- The Defense Logistics Agency (DLA) awarded a $2,278.36 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster (shingles) and related...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a ceiling value of $3,560.82 and an ultimate completion date of August 28, 2025. This firm fixed-price contract, awarded on August 27, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SHINGRIX vial kits, valued at $1,139.18, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. SHINGRIX is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) in adults and represents a...
- The Defense Logistics Agency awarded a delivery order valued at $3,417.54 to AmerisourceBergen Drug Corp for Shingrix vial kits on July 28, 2025, with completion expected by July 29, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. Shingrix is a recombinant zoster vaccine used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits with a ceiling value of $1,139.18. This firm fixed-price contract, which was competitively awarded without a set-aside designation, has an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine commonly procured for military and veteran healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.18 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,725.78 to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster in adult populations, making this...
- The Defense Logistics Agency awarded a delivery order valued at $3,742.02 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of shingles and is a critical pharmaceutical supply for military...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRTW8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,783.60 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a critical pharmaceutical commodity within the federal military healthcare supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and prime vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceuticals, vaccines, and medical supplies to support military and veteran healthcare systems, the Defense Health Agency, and other federal customers. The company's established relationship with DLA demonstrates its capability to meet stringent federal procurement requirements across the Defense Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.8k | 8/28/25 |